Table 2 Follow-up time and anti-HBs levels during HIP treatment
Patient | Follow-up with HIP (years) | HIP transfusions (n) | HIP transfusions per year (mean) | HIP costs per year (USD) | Anti-HBs determinations (n) | Anti-HBs (IU/L) median (range) | Anti-HBs <200 IU/L n (%) | Anti-HBs <100 IU/L n (%) | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
H1 | 12.6 | 137 | 10.8 | 1512 | 134 | 259 | (38-8578) | 46 | (34.3) | 11 | (8.2) |
H2 | 10.5 | 86 | 8.2 | 1148 | 86 | 351 | (84-17567) | 21 | (24.4) | 3 | (3.5) |
H3 | 5.2 | 34 | 6.5 | 910 | 51 | 324 | (108-3555) | 9 | (17.6) | 0 | (0) |
H4 | 9.4 | 65 | 6.9 | 966 | 82 | 393 | (116-2130) | 10 | (12.2) | 0 | (0) |
H5 | 11.1 | 125 | 11.2 | 1568 | 133 | 711 | (191-3911) | 1 | (0.8) | 0 | (0) |
H6 | 5.0 | 35 | 7.0 | 980 | 37 | 518 | (166-1798) | 3 | (8.1) | 0 | (0) |
H7 | 8.7 | 69 | 7.9 | 1106 | 71 | 454 | (107-1123) | 8 | (11.3) | 0 | (0) |
H8 | 0.5 | 4 | 8.3 | 1162 | 7 | 188 | (76-578) | 4 | (57.1) | 1 | (14.3) |
H9 | 1.3 | 10 | 7.8 | 1092 | 12 | 508 | (69-1050) | 1 | (8.3) | 1 | (8.3) |
H10 | 0.9 | 8 | 9.4 | 1316 | 21 | 623 | (273-3016) | 0 | (0) | 0 | (0) |
H11 | 7.2 | 42 | 5.8 | 812 | 49 | 560 | (217-1275) | 0 | (0) | 0 | (0) |
H12 | 2.8 | 21 | 7.5 | 1050 | 39 | 512 | (166-2976) | 3 | (7.7) | 0 | (0) |
H13 | 6.1 | 41 | 6.7 | 938 | 50 | 884.5 | (101-3266) | 1 | (2) | 0 | (0) |
H14 | 2.1 | 15 | 7.2 | 1008 | 28 | 829.5 | (191-5048) | 2 | (7.1) | 0 | (0) |
H15 | 1.4 | 10 | 7.2 | 1008 | 21 | 609 | (225-2728) | 0 | (0) | 0 | (0) |
H16 | 0.5 | 4 | 7.8 | 1092 | 7 | 1939 | (156-5558) | 1 | (14.3) | 0 | (0) |
H17 | 4.9 | 33 | 6.8 | 952 | 26 | 445.5 | (95-3792) | 7 | (26.9) | 1 | (3.8) |
H18 | 1.1 | 10 | 9.5 | 1330 | 21 | 597 | (14-2489) | 3 | (14.3) | 2 | (9.5) |
H19 | 2.3 | 16 | 7.1 | 994 | 30 | 512.5 | (49-4525) | 2 | (6.7) | 1 | (3.3) |
H20 | 0.6 | 7 | 10.8 | 1512 | 12 | 775.5 | (63-1000) | 2 | (16.7) | 1 | (8.3) |
H21 | 0.9 | 10 | 11.4 | 1596 | 16 | 721.5 | (208-1000) | 0 | (0) | 0 | (0) |
All patients | 95.1 | 782 | 8.2 | 1148 | 933 | 507 | (14-17567) | 124 | (13.2) | 21 | (2.3) |